IMNN

Imunon (IMNN)

Imunon Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:IMNN

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/24	21:30	GlobeNewswire Inc.	IMUNON Announces Database Lock for Phase 2 OVATION 2 Study with IMNN-001 in Advanced Ovarian Cancer	NASDAQ:IMNN	Imunon Inc
2024/06/14	19:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMNN	Imunon Inc
2024/06/14	19:13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMNN	Imunon Inc
2024/06/14	19:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMNN	Imunon Inc
2024/06/14	19:09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMNN	Imunon Inc
2024/06/14	19:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMNN	Imunon Inc
2024/06/14	19:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMNN	Imunon Inc
2024/06/14	19:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMNN	Imunon Inc
2024/06/13	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMNN	Imunon Inc
2024/06/11	03:00	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:IMNN	Imunon Inc
2024/06/05	21:30	GlobeNewswire Inc.	First Participants Vaccinated in IMUNON’s IMNN-101 Phase 1 Clinical Trial	NASDAQ:IMNN	Imunon Inc
2024/05/23	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:IMNN	Imunon Inc
2024/05/20	21:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMNN	Imunon Inc
2024/05/16	05:16	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:IMNN	Imunon Inc
2024/05/15	21:30	GlobeNewswire Inc.	Abstract on Phase 2 Study with IMUNON’s IMNN-001 Plus Bevacizumab Accepted for Presentation at the American Society of Clinical Oncology Annual Meeting	NASDAQ:IMNN	Imunon Inc
2024/05/15	05:24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMNN	Imunon Inc
2024/05/13	22:00	GlobeNewswire Inc.	IMUNON Announces Site Activation for IMNN-101 Phase 1 Vaccine Study	NASDAQ:IMNN	Imunon Inc
2024/05/13	21:10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IMNN	Imunon Inc
2024/05/13	21:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMNN	Imunon Inc
2024/05/13	21:00	GlobeNewswire Inc.	IMUNON Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:IMNN	Imunon Inc
2024/05/08	21:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMNN	Imunon Inc
2024/05/08	21:00	GlobeNewswire Inc.	IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO	NASDAQ:IMNN	Imunon Inc
2024/05/07	00:00	GlobeNewswire Inc.	IMUNON to Hold First Quarter 2024 Financial Results and Business Update Conference Call on Monday, May 13, 2024	NASDAQ:IMNN	Imunon Inc
2024/04/18	21:30	GlobeNewswire Inc.	IMUNON’s IND Application Cleared to Begin Human Testing of IMNN-101	NASDAQ:IMNN	Imunon Inc
2024/04/11	21:00	GlobeNewswire Inc.	IMUNON Reports Compliance with Nasdaq Listing Requirements	NASDAQ:IMNN	Imunon Inc
2024/03/28	21:00	GlobeNewswire Inc.	IMUNON Reports 2023 Financial Results and Provides Business Update	NASDAQ:IMNN	Imunon Inc
2024/03/25	21:30	GlobeNewswire Inc.	IMUNON Receives $1.3 Million from Sale of its New Jersey Net Operating Losses	NASDAQ:IMNN	Imunon Inc
2024/03/22	06:00	GlobeNewswire Inc.	IMUNON to Hold 2023 Financial Results and Business Update Conference Call on Thursday, March 28, 2024	NASDAQ:IMNN	Imunon Inc
2024/03/13	21:00	GlobeNewswire Inc.	IMUNON Files IND Application to Begin Human Testing of IMNN-101	NASDAQ:IMNN	Imunon Inc
2024/03/13	06:00	GlobeNewswire Inc.	IMUNON Announces Leadership Change	NASDAQ:IMNN	Imunon Inc